Hongkongers Start Receiving BioNTech Jabs
"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1579748_1_20210310182932.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1579748-20210310.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1579748-20210310.htm', 'DCS.dcsqry', '' ); } } }); }); });
2021-03-10 HKT 13:14
Hong Kong on Wednesday began inoculating people against coronavirus with Germany's BioNTech vaccine, with some of those first in the queue saying they believe it will be safer and more effective than the Sinovac jab also available.
Seven centres – in Sai Ying Pun, Sai Wan Ho, Kowloon Tong, Kwun Tong, Lai Chi Kok, Sheung Shui and Yuen Long are now providing the BioNTech jabs, for priority groups at first.
Many of those who had booked appointments at the Kowloon Tong centre on Wednesday were foreign residents. People RTHK spoke to said they were confident about receiving the vaccine.
“I’m not afraid at all. Not at all. Because they have a full medical report published, and millions and millions of people abroad have already taken the jabs. I know there are no serious side effects,” said an 80-year-old man.
A pharmacist surnamed Lam agreed that any side effects should be mild.
"From overseas experience, this vaccine is also used in high risk groups, for the elderly and also people with chronic diseases. I have confidence in this vaccine," she said.
A 76-year-old man surnamed Azim said he was not concerned about having an adverse reaction to the jab.
“I’m in good health, so no problem for me,” he laughed.
“We were told that Pfizer/BioNTech is the best. Pfizer has more efficacy,” he added.
A man surnamed Lam, meanwhile, said he didn't want to take the Sinovac jab after seeing news reports about deaths and hospitalisations among people who had received it.
“I’m not confident about it. You can see on the news, one case after another. If I’m unlucky, I might be one of them,” he said.
Authorities and experts have said they don't believe the recent deaths were linked to the Sinovac jabs, and some of those taking the BioNTech vaccine on Wednesday said they would have preferred to get the China-made vaccine, but couldn't get an appointment slot.
Most of the people RTHK spoke to said they felt fine after having the BioNTech jab. They will need to take a second dose after three weeks.
ZA Bank Brings Nasdaq Data To Hong Kong, Expanding US Stock Access And Investor Education
ZA Bank and Nasdaq have announced a collaboration aimed at enhancing digital wealth management in Hong Kong and interna... Read more
Hong Kong To Study One‑Stop Infrastructure For Equities, Bonds And Digital Assets
The Hong Kong Monetary Authority’s (HKMA) CMU OmniClear and the Hong Kong Exchange (HKEX) are set to begin a study on... Read more
Hong Kong To Issue First Stablecoin Licenses In March, Expand Crypto Regulation
Hong Kong will issue its first licenses for fiat-referenced stablecoin issuers in March and introduce new legislation l... Read more
MSIG Joins US$6B IFC Credit Insurance Facility To Boost Emerging Market Lending
MSIG USA and Mitsui Sumitomo Insurance (MSI Japan), together referred to as MSIG, have joined a new insurance-ba... Read more
Why The $2 Trillion Stablecoin Prediction Is Too Low
McKinsey estimates the stablecoin market will hit $2 trillion by 2028. But according to Sam Lin, COO of dtcpay, even th... Read more
RedotPay Eyes US IPO With Potential US$1 Billion Raise
RedotPay is reportedly exploring an IPO in the US that could raise more than US$1 billion, according to people famili... Read more